Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 7, 2003, Pages 2358-2361

  Wagner, Jutta ^a   Jabbusch, Miriam ^a   Eisenblätter, Martin ^a   Hahn, Helmut ^a   Wendt, Constanze ^b   Ignatius, Ralf ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 METHOXYQUINOLONE; CIPROFLOXACIN; CLINDAMYCIN; ENROFLOXACIN; ERYTHROMYCIN; MOXIFLOXACIN; QUINOLONE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; GERMANY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; CAMPYLOBACTER JEJUNI; CIPROFLOXACIN; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FLUOROQUINOLONES; GERMANY; HUMANS; MICROBIAL SENSITIVITY TESTS; QUINOLINES; TETRACYCLINE;

EID: 0038650922     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.7.2358-2361.2003     Document Type: Article

References (31)

1. Adler-Mosca, H., J. Luthy-Hottenstein, G. Martinetti Lucchini, A. Burnens, and M. Altwegg. 1991. Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin. Eur. J. Clin. Microbiol. Infect. Dis. 10:953-957.
2. Atanassova, V., and C. Ring. 1999. Prevalence of Campylobacter spp. in poultry and poultry meat in Germany. Int. J. Food Microbiol. 51:187-190.
3. Bauernfeind, A. 1997. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J. Antimicrob. Chemother. 40:639-651.
4. Bebear, C. M., H. Renaudin, A. Boudjadja, and C. Bebear. 1998. In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas. Antimicrob. Agents Chemother. 42:703-704.
5. Chatzipanagiotou, S., E. Papavasileiou, A. Lakumenta, A. Makri, C. Nicolaou, K. Chantzis, S. Manganas, and N. I. Legakis. 2002. Antimicrobial susceptibility patterns of Campylobacter jejuni strains isolated from hospitalized children in Athens, Greece. J. Antimicrob. Chemother. 49:803-805.
6. Coyle, E. A., G. W. Kaatz, and M. J. Rybak. 2001. Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45:1654-1659.
7. Endtz, H. P., G. J. Ruijs, B. van Klingeren, W. H. Jansen, T. van der Reyden, and R. P. Mouton. 1991. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother. 27:199-208.
8. Fass, R. J. 1997. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone. Antimicrob. Agents Chemother. 41:1818-1824.
9. Gaudreau, C., and H. Gilbert. 1998. Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. Antimicrob. Agents Chemother. 42:2106-2108.
10. Gaunt, P. N., and L. J. Piddock. 1996. Ciprofloxacin resistant Campylobacter spp. in humans: an epidemiological and laboratory study. J. Antimicrob. Chemother. 37:747-757.
11. Ge, B., S. Bodeis, R. D. Walker, D. G. White, S. Zhao, P. F. McDermott, and J. Meng. 2002. Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter. J. Antimicrob. Chemother. 50:487-494.
12. Gibreel, A., E. Sjögren, B. Kaijser, B. Wretlind, and O. Sköld. 1998. Rapid emergence of high-level resistance to quinolones in Campylobacter jejuni associated with mutational changes in gyrA and parC. Antimicrob. Agents Chemother. 42:3276-3278.
13. Grasmick, A. 1992. Processing and interpretation of bacterial fecal cultures. In H. D. Isenberg (ed.) Clinical microbiology procedures handbook, vol. 1, p. 1.10.1-1.10.25. American Society for Microbiology, Washington, D.C.
14. Jacobs-Reitsma, W. F., C. A. Kan, and N. M. Bolder. 1994. The induction of quinolone resistance in Campylobacter bacteria in broilers by quinolone treatment. Lett. Appl. Microbiol. 19:228-231.
15. McDermott, P. F., S. M. Bodeis, L. L. English, D. G. White, R. D. Walker, S. Zhao, S. Simjee, and D. D. Wagner. 2002. Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones. J. Infect. Dis. 185:837-840.
16. Pfaller, M. A., R. J. Hollis, and H. S. Sader. 1992. PFGE analysis of chromosomal restriction fragments. In H. D. Isenberg (ed.), Clinical microbiology procedures handbook, vol. 2, p. 10.5.c.1-10.5.c.12. American Society for Microbiology, Washington, D.C.
17. Prats, G., B. Mirelis, T. Llovet, C. Munoz, E. Miró, and F. Navarro. 2000. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona. Antimicrob. Agents Chemother. 44:1140-1145.
18. Rautelin, H., O. V. Renkonen, and T. U. Kosunen. 1991. Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob. Agents Chemother. 35:2065-2069.
19. Reina, J., M. J. Ros, and A. Serra. 1994. Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients. Antimicrob. Agents Chemother. 38:2917-2920.
20. Robert-Koch-Institut. 2002. Epidemiologisches Bulletin 3/2002. Aktuelle Statistik der meldepflichtigen Infektionskrankheiten. Stand 31:12.2001. Robert-Koch-Institut, Berlin, Germany.
21. Rodriguez, J. C., M. Ruiz, A. Climent, and G. Royo. 2001. In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis. Int. J. Antimicrob. Agents 17:229-231.
22. Schmitz, F. J., K. Kohrer, S. Scheuring, J. Verhoef, A. Fluit, H. P. Heinz, and M. E. Jones. 1991). The stability of grlA, grlB, gyrA, gyrB and norA mutations and MIC values of the fluoroquinolones in three different clonal populations of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 5:287-290.
23. Sjogren, E., G. B. Lindblom, and B. Kaijser. 1997. Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. J. Antimicrob. Chemother. 40:257-261.
24. Smith, K. E., J. M. Besser, C. W. Hedberg, F. T. Leano, J. B. Bender, J. H. Wicklund, B. P. Johnson, K. A. Moore, M. T. Osterholm, and the Investigation Team. 1999. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N. Engl. J. Med. 340:1525-1532.
25. Steele, M., B. McNab, L. Fruhner, S. DeGrandis, D. Woodward, and J. A. Odumeru. 1998. Epidemiological typing of Campylobacter isolates from meat processing plants by pulsed-field gel electrophoresis, fatty acid profile typing, serotyping, and biotyping. Appl. Environ. Microbiol. 64:2346-2349.
26. Talsma, E., W. G. Goettsch, H. L. Nieste, P. M. Sehrijnemakers, and M. J. Sprenger. 1999. Resistance in Campylobacter species: increased resistance to fluoroquinolones and seasonal variation. Clin. Infect. Dis. 29:845-848.
27. Tankovic, J., R. Bachoual, S. Ouabdesselam, A. Boudjadja, and C. J. Soussy. 1999. In-vitro activity of moxifloxacin against fluoroquinolone-resistant strains of aerobic gram-negative bacilli and Enterococcus faecalis. J. Antimicrob. Chemother. 43(Suppl. B):19-23.
28. Thwaites, R. T., and J. A. Frost. 1999. Drug resistance in Campylobacter jejuni, C. coli, and C. lari isolated from humans in northwest England and Wales, 1997. J. Clin. Pathol. 52:812-814.
29. van den Bogaard, A. E., and E. E. Stobberingh. 1999. Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs 58:589-607.
30. Wang, Y., W. M. Huang, and D. E. Taylor. 1993. Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations. Antimicrob. Agents Chemother. 37:457-463.
31. Woodcock, J. M., J. M. Andrews, F. J. Boswell, N. P. Brenwald, and R. Wise. 1997. In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrob. Agents Chemother. 41:101-106.